AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models. - Greer-Short A; Greenwood A; Leon EC; Qureshi TN; von Kraut K; Wong J; Tsui JH; Reid CA; Cheng Z; Easter E; Yang J; Ho J; et al. (Nature communications, 2025)